- Home
- FLNT vs IMMX Comparison
FLNT vs IMMX Comparison
Compare FLNT & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLNT
- IMMX
- Stock Information
- Founded
- FLNT 2010
- IMMX 2014
- Country
- FLNT United States
- IMMX United States
- Employees
- FLNT N/A
- IMMX N/A
- Industry
- FLNT Advertising
- IMMX Medicinal Chemicals and Botanical Products
- Sector
- FLNT Consumer Discretionary
- IMMX Health Care
- Exchange
- FLNT Nasdaq
- IMMX Nasdaq
- Market Cap
- FLNT 58.9M
- IMMX 55.3M
- IPO Year
- FLNT N/A
- IMMX 2021
- Fundamental
- Price
- FLNT $2.81
- IMMX $1.76
- Analyst Decision
- FLNT Hold
- IMMX Strong Buy
- Analyst Count
- FLNT 1
- IMMX 1
- Target Price
- FLNT $4.00
- IMMX $7.00
- AVG Volume (30 Days)
- FLNT 6.4K
- IMMX 83.5K
- Earning Date
- FLNT 04-01-2025
- IMMX 03-28-2025
- Dividend Yield
- FLNT N/A
- IMMX N/A
- EPS Growth
- FLNT N/A
- IMMX N/A
- EPS
- FLNT N/A
- IMMX N/A
- Revenue
- FLNT $261,976,999.00
- IMMX N/A
- Revenue This Year
- FLNT N/A
- IMMX N/A
- Revenue Next Year
- FLNT $10.36
- IMMX $600.00
- P/E Ratio
- FLNT N/A
- IMMX N/A
- Revenue Growth
- FLNT N/A
- IMMX N/A
- 52 Week Low
- FLNT $2.31
- IMMX $1.26
- 52 Week High
- FLNT $4.30
- IMMX $3.80
- Technical
- Relative Strength Index (RSI)
- FLNT 45.52
- IMMX 31.71
- Support Level
- FLNT $2.87
- IMMX $1.85
- Resistance Level
- FLNT $3.05
- IMMX $2.14
- Average True Range (ATR)
- FLNT 0.16
- IMMX 0.12
- MACD
- FLNT -0.01
- IMMX -0.02
- Stochastic Oscillator
- FLNT 13.78
- IMMX 8.43
About FLNT Fluent Inc.
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers they are seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.